Paid Advertisement
Join us for 3 CME/CE-certified satellite symposia designed to help healthcare professionals stay ahead of evolving cardiovascular care. Experts will share practical strategies and insights on OSA and cardiovascular disease, heart failure, and severe hypertriglyceridemia. Reserve your spot to attend all three events by registering at deceraclinical.com/HeartChicago26
Don’t Miss a Beat! Seizing Opportunities for OSA Management in Cardiovascular Care
Friday, November 6, 2026
Registration & Dinner: 6:30 PM - 7:00 PM CT
Symposium: 7:00 PM - 8:30 PM CT
Marriott Marquis Chicago
2121 S Prairie Ave
Chicago, Illinois 60616
Shedd AB (2nd floor)
This CME-certified educational curriculum is designed to help cardiologists improve the identification and management of patients with obstructive sleep apnea (OSA) and cardiovascular disease. The program uses interactive, case-based education to strengthen healthcare professionals’ ability to identify, screen, and treat patients with OSA and collaborate effectively with sleep medicine and other specialists.
Physicians: 1.50 AMA PRA Category 1 Credits™
Faculty
Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA, FACP
Radhika S. Breaden, MD, MPH, DABMS, FAASM, DABOM
Rafael J. Sepulveda, MD, FAASM, D-ABOM
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize cardiology patients who should be screened for OSA
- Analyze results of OSA screening and diagnostic testing to identify patients who would benefit from referral to sleep medicine specialists
- Implement collaborative care strategies to effectively support OSA management as part of comprehensive CVD care
- Evaluate recent evidence for pharmacologic therapies for patients with OSA and obesity
Provided by
Provided by Clinical Care Options, LLC dba Decera Clinical Education
Supporters
This activity is supported by an educational grant from Lilly.
The HF Huddle: Winning Strategies for Early Detection and Evidence-Based Treatment in Heart Failure
Saturday, November 7, 2026
Registration & Dinner: 5:30 PM - 6:00 PM CT
Symposium: 6:00 PM - 7:30 PM CT
Marriott Marquis Chicago
2121 S Prairie Ave
Chicago, Illinois 60616
Shedd AB (2nd floor)
This interactive CME/CE activity will help cardiology healthcare professionals (HCPs) improve the recognition, risk stratification, and management of patients with heart failure across the ejection fraction spectrum. Learners will engage with AI-generated patient–HCP scenarios, interactive polling, and expert analysis focused on contemporary diagnostic strategies and practical implementation of guideline-directed medical therapy.
Physicians: maximum of 1.50 AMA PRA Category 1 Credits™
Physician Associates: 1.50 AAPA Category 1 CME credits
Nurse Practitioners/Nurses: 1.50 Nursing contact hours
Faculty
Lauren S. Eyadiel, MMS, MS, PA-C, FHFSA
Ty J. Gluckman, MD, MHA
Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
Learning Objectives
Upon completion of this activity, participants should be able to:
- Apply current understanding of heart failure pathophysiology across the ejection fraction spectrum (HFrEF, HFmrEF, HFpEF), including neurohormonal and cardiometabolic mechanisms, to inform clinical evaluation and risk stratification
- Integrate contemporary diagnostic strategies, including biomarkers, advanced imaging, and validated clinical scoring systems, to identify heart failure earlier in disease progression and support accurate phenotyping
- Implement guideline-directed medical therapy (GDMT) for patients with heart failure by strategically initiating, titrating, and sequencing evidence-based treatments in alignment with current guideline recommendations, while addressing cardiometabolic comorbidities and managing treatment-related adverse effects
Provided by
Provided by Clinical Care Options, LLC dba Decera Clinical Education
Supporters
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
MISSION POSSIBLE: Elevating Risk Recognition, Treatment Decisions, and Pancreatitis Prevention in Severe Hypertriglyceridemia
Sunday, November 8, 2026
Registration & Breakfast: 6:00 AM - 6:30 AM CT
Symposium: 6:30 AM - 8:00 AM CT
McCormick Place Convention Center
2301 S. Dr. Martin Luther King Jr. Drive
Chicago, Illinois 60616
Industry Meeting Room, Level 4, N427D
This CME/CE-certified educational curriculum provides cardiologists with practical, case-based education to enhance the recognition and management of patients with severe hypertriglyceridemia (sHTG) and reduce the risk of acute pancreatitis. The activity focuses on strengthening healthcare professionals’ ability to assess risk, optimize triglyceride-lowering therapy, and incorporate emerging treatment options into clinical practice.
Physicians: maximum of 1.50 AMA PRA Category 1 Credits™
Physician Associates: 1.50 AAPA Category 1 CME credits
Nurse Practitioners/Nurses: 1.50 Nursing contact hours
Faculty
Zahid Ahmad, MD, FNLA
Robert P. Giugliano, MD, SM
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify patients with severe hypertriglyceridemia (sHTG) through appropriate risk assessment, lipid evaluation, and recognition of key clinical indicators.
- Assess current and emerging treatment approaches for severe hypertriglyceridemia, incorporating patient-specific cardiovascular risk factors and comorbidities.
- Apply guideline-based management strategies to optimize triglyceride lowering, improve cardiometabolic health, and reduce the likelihood of acute pancreatitis in patients with sHTG.
Provided by
Provided by Clinical Care Options, LLC dba Decera Clinical Education
Supporters
This activity is supported by Ionis Pharmaceuticals, Inc.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
These events are not part of the official Scientific Sessions 2026 as planned by the AHA Committee on Scientific Sessions Programming